« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 124, Issue 3
, Pages
435-441
, September 2002
The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease
-
Hemodynamic variables during the study protocol. All values are displayed as means ± SEM. Statistical significance of the change of a variable in response to the next study protocol condition is indic
Hemodynamic variables during the study protocol. All values are displayed as means ± SEM. Statistical significance of the change of a variable in response to the next study protocol condition is indicated as follows: *P < .05 and **P < .01. NS, Not significant; inhNO, inhaled NO.
-
Metabolic variables and derived cardiac output during the study protocol. All values are displayed as means ± SEM. Statistical significance of the change of a variable in response to the next study prMetabolic variables and derived cardiac output during the study protocol. All values are displayed as means ± SEM. Statistical significance of the change of a variable in response to the next study protocol condition is indicated as follows: *P < .05 and **P < .01. NS, Not significant; inhNO, inhaled NO.
-
Vascular resistance during the study protocol. All values are displayed as means ± SEM. Statistical significance of the change of a variable in response to the next study protocol condition is indicatVascular resistance during the study protocol. All values are displayed as means ± SEM. Statistical significance of the change of a variable in response to the next study protocol condition is indicated as follows: *P < .05 and **P < .01. NS, Not significant; inhNO, inhaled NO.
-
Correlation of plasma endothelin levels and PVR response to ETA blockade. The arterial ET-1 concentration is related to the decrease of PVR in response to BQ123 infusion (r2 = 0.89, P < .05).Correlation of plasma endothelin levels and PVR response to ETA blockade. The arterial ET-1 concentration is related to the decrease of PVR in response to BQ123 infusion (r2 = 0.89, P < .05).
☆ This work was made possible by a grant from the National Heart Research Fund (No. 99-CC-10), Leeds, United Kingdom.
☆☆ Address for reprints: D. J. Penny, MD, Cardiology Department, Royal Children's Hospital, Flemington Rd, Parkville, Victoria 3052, Australia (E-mail: pennyd@cryptic.rch.unimelb.edu.au).
PII: S0022-5223(02)00104-6
doi: 10.1067/mtc.2002.121492
© 2002 American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 124, Issue 3
, Pages
435-441
, September 2002
